Adicet Bio, Inc.

NASDAQ: ACET · Healthcare · Biotechnology

PublicHQ Boston, MA · SuffolkCIK 0001720580Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 43DQ —GM —SS 58

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, workforce scale · ↓ Piotroski F, return on equity

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$116.8M

Employees

152

Market cap

$84.1M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$116.8M-$116.8M2025

Operating income-$122.1M-$122.1M2025

Total assets$192.4M$192.4M2025

Liabilities$33.1M$33.1M2025

Equity$159.2M$159.2M2025

Revenue by segment

Filed disclosures · FY2017

By product

Human Health49%

Performance Chemicals26%

Pharmaceutical Ingredients25%

By geography

UNITED STATES76%

GERMANY12%

FRANCE6%

Asia Pacific5%

NETHERLANDS2%

The read

Adicet Bio, Inc. earned -$116.8M in FY2025 net income.

Peers · Healthcare

OS Therapies Incorporated——Biomea Fusion, Inc.——Definitive Healthcare Corp.53D Cognition Therapeutics, Inc.——

Neighbors

Suffolk →

Vertex Pharmaceuticals Incorporated$12.0B88A American Tower Corporation$935.9M75B+State Street Corporation$13.9B67B NSTAR Electric Company——Toast, Inc.$6.2B67B PTC Inc.$2.7B84B+

Key facts

CEOChen Schor

SectorHealthcare

IndustryBiotechnology

HeadquartersBoston, MA

ExchangeNASDAQ: ACET

Employees152

IPO date2018-01-26

Latest filings

8-K2026-06-18 8-K2026-05-13 10-Q2026-05-13 DEF 14A2026-04-29 8-K2026-04-28 8-K2026-03-12 10-K2026-03-12 8-K2026-01-07

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.